Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

CotH3 mediates fungal invasion of host cells during mucormycosis
Teclegiorgis Gebremariam, … , Michael R. Yeaman, Ashraf S. Ibrahim
Teclegiorgis Gebremariam, … , Michael R. Yeaman, Ashraf S. Ibrahim
Published December 20, 2013
Citation Information: J Clin Invest. 2014;124(1):237-250. https://doi.org/10.1172/JCI71349.
View: Text | PDF
Research Article Article has an altmetric score of 30

CotH3 mediates fungal invasion of host cells during mucormycosis

  • Text
  • PDF
Abstract

Angioinvasion is a hallmark of mucormycosis. Previously, we identified endothelial cell glucose-regulated protein 78 (GRP78) as a receptor for Mucorales that mediates host cell invasion. Here we determined that spore coat protein homologs (CotH) of Mucorales act as fungal ligands for GRP78. CotH proteins were widely present in Mucorales and absent from noninvasive pathogens. Heterologous expression of CotH3 and CotH2 in Saccharomyces cerevisiae conferred the ability to invade host cells via binding to GRP78. Homology modeling and computational docking studies indicated structurally compatible interactions between GRP78 and both CotH3 and CotH2. A mutant of Rhizopus oryzae, the most common cause of mucormycosis, with reduced CotH expression was impaired for invading and damaging endothelial cells and CHO cells overexpressing GRP78. This strain also exhibited reduced virulence in a diabetic ketoacidotic (DKA) mouse model of mucormycosis. Treatment with anti-CotH Abs abolished the ability of R. oryzae to invade host cells and protected DKA mice from mucormycosis. The presence of CotH in Mucorales explained the specific susceptibility of DKA patients, who have increased GRP78 levels, to mucormycosis. Together, these data indicate that CotH3 and CotH2 function as invasins that interact with host cell GRP78 to mediate pathogenic host-cell interactions and identify CotH as a promising therapeutic target for mucormycosis.

Authors

Teclegiorgis Gebremariam, Mingfu Liu, Guanpingsheng Luo, Vincent Bruno, Quynh T. Phan, Alan J. Waring, John E. Edwards Jr., Scott G. Filler, Michael R. Yeaman, Ashraf S. Ibrahim

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 Total
Citations: 6 15 22 25 25 12 12 8 9 4 4 7 1 150
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2022 (25)

Title and authors Publication Year
COVID-19 associated mucormycosis – An emerging threat
C Chao, C Lai, W Yu
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 2022
Mucormycosis: A new threat to Coronavirus disease 2019 with special emphasis on India
D Ghosh, S Dey, H Chakraborty, S Mukherjee, A Halder, A Sarkar, P Chakraborty, R Ghosh, J Sarkar
Clinical Epidemiology and Global Health 2022
Recent Advances and Future Directions in the Understanding of Mucormycosis
V Garre
Frontiers in Cellular and Infection Microbiology 2022
Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach
A Azhar, W Khan, P Khan, K Alhosaini, M Owais, A Ahmad
Journal of Infection and Public Health 2022
In silico prediction and structure-based multitargeted molecular docking analysis of selected bioactive compounds against mucormycosis
P Madanagopal, N Ramprabhu, R Jagadeesan
2022
New insights on mucormycosis and its association with the COVID-19 pandemic
M Alshahawey, G El-Housseiny, N Elsayed, M Alshahrani, L Wakeel, K Aboshanab
Future Science OA 2022
Novel Secreted Peptides From Rhizopus arrhizus var. delemar With Immunomodulatory Effects That Enhance Fungal Pathogenesis
S Soliman, E El-Labbad, A Abu-Qiyas, B Fayed, A Hamoda, A Al-Rawi, S Dakalbab, A El-Shorbagi, M Hamad, A Ibrahim, M Mohammad
Frontiers in microbiology 2022
A bacterial endosymbiont of the fungus Rhizopus microsporus drives phagocyte evasion and opportunistic virulence
H Itabangi, P Sephton-Clark, D Tamayo, X Zhou, G Starling, Z Mahamoud, I Insua, M Probert, J Correia, P Moynihan, T Gebremariam, Y Gu, A Ibrahim, G Brown, J King, E Ballou, K Voelz
Current biology : CB 2022
Serum glucose-regulated protein 78 (GRP78) levels in COVID-19-associated mucormycosis: results of a case–control study
V Muthu, M Dhaliwal, A Sharma, D Nair, H Kumar, S Rudramurthy, I Sehgal, H Choudhary, N Panda, A Chakrabarti, R Agarwal
Mycopathologia 2022
Mucormycosis Amid COVID-19 Crisis: Pathogenesis, Diagnosis, and Novel Treatment Strategies to Combat the Spread
Dogra S, Arora A, Aggarwal A, Passi G, Sharma A, Singh G, Barnwal RP
Frontiers in microbiology 2022
A Novel Prognostic Signature Based on Glioma Essential Ferroptosis-Related Genes Predicts Clinical Outcomes and Indicates Treatment in Glioma
Yun D, Wang X, Wang W, Ren X, Li J, Wang X, Liang J, Liu J, Fan J, Ren X, Zhang H, Shang G, Sun J, Chen L, Li T, Zhang C, Yu S, Yang X
Frontiers in Oncology 2022
Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis
García-Carnero LC, Mora-Montes HM
Journal of Fungi 2022
Mini Review: Risk Assessment, Clinical Manifestation, Prediction, and Prognosis of Mucormycosis: Implications for Pathogen- and Human-Derived Biomarkers
Acosta-España JD, Voigt K
Frontiers in microbiology 2022
COVID-19-associated fungal infections
Hoenigl M, Seidel D, Sprute R, Cunha C, Oliverio M, Goldman GH, Ibrahim AS, Carvalho A
Nature Microbiology 2022
Lipase-Catalyzed Synthesis, Antioxidant Activity, Antimicrobial Properties and Molecular Docking Studies of Butyl Dihydrocaffeate
Zieniuk B, Ononamadu CJ, Jasińska K, Wierzchowska K, Fabiszewska A
Molecules (Basel, Switzerland) 2022
COVID-19-associated Mucormycosis: A clinico-epidemiological study
Chakravarty J, Gupta MK, Tilak R, kumar R, Maurya RP, Kumar N, Agarwal SK, S S, Sharma NK, Dhiman NK, Manaswichaubey, Singh V, verma A, Banerjee T, Agarwal NK, Prasad RS
Journal of Diabetes and its Complications 2022
COVID-19-Associated mucormycosis: Case series from a tertiary care hospital in South India
Rashbi K. S, Ali TM, P. N. D, C. K. S, Payyappilly RJ
2022
COVID-19-Associated Mucormycosis: A Matter of Concern Amid the SARS-CoV-2 Pandemic
Chandley P, Subba P, Rohatgi S
Human vaccines 2022
Potential inhibitory activity of phytoconstituents against black fungus: In silico ADMET, molecular docking and MD simulation studies
Hamaamin Hussen N, Hameed Hasan A, Jamalis J, Shakya S, Chander S, Kharkwal H, Murugesan S, Ajit Bastikar V, Pyarelal Gupta P
2022
The TLR-NF-kB axis contributes to the monocytic inflammatory response against a virulent strain of Lichtheimia corymbifera, a causative agent of invasive mucormycosis.
Montaño DE, Hartung S, Wich M, Ali R, Jungnickel B, von Lilienfeld-Toal M, Voigt K
Frontiers in immunology 2022
Diabetic ketoacidosis and coronavirus disease 2019-associated mucormycosis: a case report.
Monroig V, Tarquinio KM
Journal of medical case reports 2022
Mucormycosis: A comparative update between conventional and molecular diagnosis strategies.
Mudgal S, Rao S, Pai MO
Current Medical Mycology 2022
An old confusion: Entomophthoromycosis versus mucormycosis and their main differences
Acosta-España JD, Voigt K
Frontiers in microbiology 2022
Focusing COVID-19-associated mucormycosis: a major threat to immunocompromised COVID-19.
Sharma N, Wani SN, Behl T, Singh S, Zahoor I, Sehgal A, Bhatia S, Al-Harrasi A, Aleya L, Bungau S
Environmental Science and Pollution Research 2022
Myosin-II proteins are involved in the growth, morphogenesis, and virulence of the human pathogenic fungus Mucor circinelloides
Trieu TA, Nguyen PA, Le MN, Chu HN
Frontiers in Cellular and Infection Microbiology 2022

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 4 news outlets
Posted by 3 X users
Highlighted by 1 platforms
188 readers on Mendeley
See more details